I don't dispute the evidence the Mastitis is a $50 billion dollar global problem. The key question is what revenue POH can realistically expect to generate?
Anyone that has followed bio companies know they all engage in the the 'it's a xx billion dollar market' game, but the revenue available to them is only a fraction of that "potential" What do people think POH can generate in its first year (Sep 11 - Sep 12)? I doubt they could do more than $1m at best.
it`s the balance sheet stupid, page-47
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
